Stock Scorecard



Stock Summary for Surface Oncology Inc (SURF) - $0.00 as of 12/9/2023 11:19:16 PM EST

Total Score

3 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for SURF

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SURF

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SURF

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for SURF

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for SURF

Why Coherus BioSciences Stock Is Sinking Today 1/23/2024 4:37:00 PM
Why Coherus Biosciences Stock Dropped Today 11/7/2023 8:37:00 PM
Coherus Presents Data from Next-generation Immuno-oncology Programs at 38th Annual Meeting of Society for Immunotherapy of Cancer ( SITC ) 11/3/2023 12:30:00 PM
Coherus Presents Data from Next-generation Immuno-oncology Programs at 38th Annual Meeting of Society for Immunotherapy of Cancer ( SITC ) - Coherus BioSciences ( NASDAQ:CHRS ) 11/3/2023 12:30:00 PM
Coherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 10/14/2023 4:30:00 PM
Coherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Coherus BioSciences ( NASDAQ:CHRS ) 10/14/2023 4:30:00 PM
Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo 10/4/2023 9:01:00 PM
CIMERLI® ( ranibizumab-eqrn ) Sales Exceed 100,000 Doses in First Year of Launch - Coherus BioSciences ( NASDAQ:CHRS ) 10/4/2023 12:30:00 PM
Coherus Applauds Congressional Designation of September 30th as Rare Cancer Day - Coherus BioSciences ( NASDAQ:CHRS ) 10/2/2023 1:00:00 PM
Coherus Announces Three Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer ( SITC ) 9/27/2023 1:10:00 PM

Financial Details for SURF

Company Overview

Ticker SURF
Company Name Surface Oncology Inc
Country N/A
Description N/A
Sector Name N/A
Industry Name N/A
Most Recent Quarter N/A
Next Earnings Date N/A

Stock Price History

Last Day Price 0.00
Last Day Price Updated 12/9/2023 11:19:16 PM EST
Last Day Volume N/A
Average Daily Volume N/A
52-Week High 0.00
52-Week Low 0.00
Last Price to 52 Week Low 0.00%

Valuation Measures

Trailing PE N/A
Industry PE N/A
Sector PE N/A
5-Year Average PE 0.00
Free Cash Flow Ratio 0.00
Industry Free Cash Flow Ratio N/A
Sector Free Cash Flow Ratio N/A
Current Ratio Most Recent Quarter 0.00
Total Cash Per Share 0.00
Book Value Per Share Most Recent Quarter 0.00
Price to Book Ratio 0.00
Industry Price to Book Ratio N/A
Sector Price to Book Ratio N/A
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months N/A
Sector Price to Sales Ratio Twelve Trailing Months N/A

Share Statistics

Total Shares Outstanding 0
Market Capitalization 0
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 0.00%
Reported EPS 12 Trailing Months 0.00
Reported EPS Past Year 0.00
Reported EPS Prior Year 0.00
Net Income Twelve Trailing Months 0
Net Income Past Year 0
Net Income Prior Year 0
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 0
Total Cash Past Year 0
Total Cash Prior Year 0
Net Cash Position Most Recent Quarter 0
Net Cash Position Past Year 0
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 0.00
Equity to Debt Ratio Most Recent Quarter 0.00
Total Stockholder Equity Past Year 0
Total Stockholder Equity Prior Year 0
Total Stockholder Equity Most Recent Quarter 0

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.00
RSI 0.00
50-Day SMA 0.00
200-Day SMA 0.00

System

Modified 12/15/2023 8:33:11 AM EST